PROCTER & GAMBLE HEALTH | PIRAMAL PHARMA | PROCTER & GAMBLE HEALTH/ PIRAMAL PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 34.6 | -212.5 | - | View Chart |
P/BV | x | 10.6 | 2.8 | 379.7% | View Chart |
Dividend Yield | % | 2.0 | 0.0 | - |
PROCTER & GAMBLE HEALTH PIRAMAL PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
PROCTER & GAMBLE HEALTH Jun-23 |
PIRAMAL PHARMA Mar-23 |
PROCTER & GAMBLE HEALTH/ PIRAMAL PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 5,366 | 202 | 2,658.9% | |
Low | Rs | 3,883 | 63 | 6,150.8% | |
Sales per share (Unadj.) | Rs | 740.7 | 59.3 | 1,248.2% | |
Earnings per share (Unadj.) | Rs | 138.2 | -1.6 | -8,846.9% | |
Cash flow per share (Unadj.) | Rs | 155.2 | 4.1 | 3,777.0% | |
Dividends per share (Unadj.) | Rs | 95.00 | 0 | - | |
Avg Dividend yield | % | 2.1 | 0 | - | |
Book value per share (Unadj.) | Rs | 447.6 | 56.8 | 788.6% | |
Shares outstanding (eoy) | m | 16.60 | 1,193.32 | 1.4% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 6.2 | 2.2 | 279.7% | |
Avg P/E ratio | x | 33.5 | -84.8 | -39.5% | |
P/CF ratio (eoy) | x | 29.8 | 32.2 | 92.4% | |
Price / Book Value ratio | x | 10.3 | 2.3 | 442.7% | |
Dividend payout | % | 68.7 | 0 | - | |
Avg Mkt Cap | Rs m | 76,761 | 158,073 | 48.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 2,062 | 18,964 | 10.9% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 12,296 | 70,816 | 17.4% | |
Other income | Rs m | 184 | 2,251 | 8.2% | |
Total revenues | Rs m | 12,480 | 73,067 | 17.1% | |
Gross profit | Rs m | 3,247 | 6,756 | 48.1% | |
Depreciation | Rs m | 281 | 6,767 | 4.2% | |
Interest | Rs m | 8 | 3,442 | 0.2% | |
Profit before tax | Rs m | 3,142 | -1,202 | -261.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 847 | 663 | 127.8% | |
Profit after tax | Rs m | 2,295 | -1,865 | -123.1% | |
Gross profit margin | % | 26.4 | 9.5 | 276.8% | |
Effective tax rate | % | 27.0 | -55.2 | -48.9% | |
Net profit margin | % | 18.7 | -2.6 | -708.8% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 11,713 | 48,435 | 24.2% | |
Current liabilities | Rs m | 6,791 | 38,510 | 17.6% | |
Net working cap to sales | % | 40.0 | 14.0 | 285.6% | |
Current ratio | x | 1.7 | 1.3 | 137.1% | |
Inventory Days | Days | 263 | 58 | 450.0% | |
Debtors Days | Days | 343 | 9 | 3,703.5% | |
Net fixed assets | Rs m | 10,617 | 95,931 | 11.1% | |
Share capital | Rs m | 166 | 11,933 | 1.4% | |
"Free" reserves | Rs m | 7,265 | 55,802 | 13.0% | |
Net worth | Rs m | 7,431 | 67,735 | 11.0% | |
Long term debt | Rs m | 0 | 33,835 | 0.0% | |
Total assets | Rs m | 22,330 | 144,365 | 15.5% | |
Interest coverage | x | 409.1 | 0.7 | 62,843.1% | |
Debt to equity ratio | x | 0 | 0.5 | 0.0% | |
Sales to assets ratio | x | 0.6 | 0.5 | 112.3% | |
Return on assets | % | 10.3 | 1.1 | 943.8% | |
Return on equity | % | 30.9 | -2.8 | -1,121.9% | |
Return on capital | % | 42.4 | 2.2 | 1,921.8% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 13.1 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | 1,605 | NA | - | |
Fx inflow | Rs m | 1,465 | 20,478 | 7.2% | |
Fx outflow | Rs m | 1,605 | 6,734 | 23.8% | |
Net fx | Rs m | -140 | 13,744 | -1.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 2,360 | 4,839 | 48.8% | |
From Investments | Rs m | -215 | -13,388 | 1.6% | |
From Financial Activity | Rs m | -985 | 8,178 | -12.0% | |
Net Cashflow | Rs m | 1,160 | -320 | -363.2% |
Indian Promoters | % | 0.0 | 35.0 | - | |
Foreign collaborators | % | 51.8 | 0.0 | - | |
Indian inst/Mut Fund | % | 20.0 | 42.7 | 46.8% | |
FIIs | % | 6.2 | 30.6 | 20.4% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 48.2 | 65.0 | 74.1% | |
Shareholders | 56,778 | 297,996 | 19.1% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare PROCTER & GAMBLE HEALTH With: DIVIS LABORATORIES CIPLA SUN PHARMA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | Procter & Gamble Health | PIRAMAL PHARMA | S&P BSE HEALTHCARE |
---|---|---|---|
1-Day | -0.43% | 0.28% | 0.45% |
1-Month | -1.15% | 20.03% | 2.55% |
1-Year | 0.73% | 104.22% | 56.14% |
3-Year CAGR | -8.76% | -9.46% | 15.22% |
5-Year CAGR | 4.97% | -5.79% | 19.63% |
* Compound Annual Growth Rate
Here are more details on the Procter & Gamble Health share price and the PIRAMAL PHARMA share price.
Moving on to shareholding structures...
The promoters of Procter & Gamble Health hold a 51.8% stake in the company. In case of PIRAMAL PHARMA the stake stands at 35.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Procter & Gamble Health and the shareholding pattern of PIRAMAL PHARMA.
Finally, a word on dividends...
In the most recent financial year, Procter & Gamble Health paid a dividend of Rs 95.0 per share. This amounted to a Dividend Payout ratio of 68.7%.
PIRAMAL PHARMA paid Rs 0.0, and its dividend payout ratio stood at -0.0%.
You may visit here to review the dividend history of Procter & Gamble Health, and the dividend history of PIRAMAL PHARMA.
For a sector overview, read our pharmaceuticals sector report.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.